who should not take glp 1 GLP-1 Medications Infographic Long-term Success of GLP-1s Hinges

Proteolytic Stability Attributed to D-Alanine and Studies have confirmed that Dermorphins D-Alanine at position 2 is the primary structural feature responsible for its enhanced proteolytic resistance compared to the all-L-amino acid analogue , with degradation studies documenting significantly slower enzymatic breakdown of Dermorphin compared to structurally similar L-amino acid peptides, confirming the functional significance of the D-amino acid in extending the peptides biological half-life

doi: 10.1523/JNEUROSCI.0081-05.2005 127

This is not a one-medication platform

& Ulrich, J

The processes by which the compounded drugs are manufactured have not been reviewed by the FDA